Aged Patients with type 2 Diabetes face Higher Risk of COVID-19 death
he research team of the Central South Hospital of Wuhan University has found that age-related underlying diseases, such as hypertension and diabetes, can significantly slow down the rate of virus clearance in patients with COVID-19, especially the risk of death after the specific population of type 2 diabetes suffers from COVID-19 higher.
Among patients with COVID-19, those with cancer also have a higher risk of death. The research team of the Central South Hospital of Wuhan University has found that basic age-related diseases, such as hypertension and diabetes, will significantly slow down the rate of virus clearance in patients with COVID-19.
However, few studies have shown that diabetes, especially the specific population of type 2 diabetes, has a higher risk of death after suffering from COVID-19.
Recently, a study involving Monash University found that elderly diabetes patients with COVID-19 have a higher risk of dying from the disease-the virus may actually trigger diabetes attacks in normal healthy people.
COVID-19 patients during a pandemic suffer from diabetes
The study, published in The Lancet Diabetes and Endocrinology, found that globally, 20% to 50% of patients diagnosed with COVID-19 during a pandemic suffer from diabetes. It also pointed out that among diabetics, especially elderly type 2 diabetics, the risk of dying from COVID-19 is 50% higher.
In Australia, as of April 12, one third of the 46 people who died of COVID-19 had diabetes, and 20% of the 752 hospitalized for viral infections had diabetes.
This study was completed by an international team of experts in the field of diabetes. They gathered together to provide guidance and practical advice on diabetes management for clinicians in developed and developing countries.
Professor Zimmert said the data highlights the real threat of COVID-19 to diabetics because they are more likely to develop severe pneumonia and sepsis. This research is important because it brings together the current world impact of COVID-19 on diabetics, and given that this epidemic has occurred recently, they are at increased risk.
Diabetes patients with COVID-19 have Higher Death Risk
Epidemiological observations in areas severely affected by COVID-19, and reports from the Centers for Disease Control (CDC) and other national health centers and hospitals show that among patients with COVID-19, the fatal risk of diabetes is higher than that of patients without diabetes More than 50% higher.
Most of the focus of this study is on patients with type 2 diabetes
So far, most of the information has been concentrated on the relevant elderly population, and the risk of COVID-19 in young people with type 1 diabetes seems to be much lower.
As long as they can guarantee adequate medical care and control their diabetes well. On this issue, the parents of children and adolescents have taken a heart-pill.
The study pointed out that damage to pancreatic beta cells (cells that make insulin) may cause direct damage to pancreatic function. Although this has not been confirmed in humans, researchers believe that diabetes may not only be a risk factor for severe COVID-19 disease, but infection may cause new-onset diabetes.
There is also evidence to support this finding in the potential islet β cell damage caused by the lack of insulin caused by the new coronavirus.
Other co-authors have reported that severe diabetic ketoacidosis (DKA) often occurs during hospitalization.
COVID-19 Patients Should be Tested for Diabetes
Professor Zimmert said the study recommended that people with COVID-19 infection be tested for diabetes to identify whether previously healthy people had diabetes due to infection with the virus. Because this will obviously affect their medical management and health outcomes.
According to this study, patients with diabetes have an increased risk of serious complications, including adult respiratory distress syndrome and multiple organ failure including lung, heart, and kidney.
Professor Zimmert said that diabetes care professionals engaged in the care of patients with COVID-19 should also be warned to ensure that they have the protection they need to prevent infection.
Certain subgroups of diabetics may also require special attention, including:
(1) People who have poor control of diabetes metabolism (blood sugar)
(2) People with diabetes complications (overall, people with severe COVID-19 infection have a high risk of kidney failure)
(3) Obese type 2 diabetics (this may cause management problems)
(4) Diabetic patients undergoing bariatric surgery due to obesity (needs special attention)
(5) People who have undergone pancreas and kidney transplantation, or who have undergone regular dialysis
(6) Patients receiving immunosuppressive therapy or cortisone therapy for other diseases
(7) Those who take certain diabetes drugs (if they are seriously ill, it may affect the progress of the disease)
(8) Type 2 diabetes patients with hypertension and hyperlipidemia (fat) (it is important to continue to adopt appropriate blood pressure and lipid-lowering programs)